Lower serum levels of total cholesterol are associated with higher urinary levels of 8-hydroxydeoxyguanosine

  • Hiroyuki Kikuchi1Email author,

    Affiliated with

    • Akiko Nanri1,

      Affiliated with

      • Ai Hori2,

        Affiliated with

        • Masao Sato3,

          Affiliated with

          • Kazuaki Kawai4,

            Affiliated with

            • Hiroshi Kasai4 and

              Affiliated with

              • Tetsuya Mizoue1

                Affiliated with

                Nutrition & Metabolism201310:59

                DOI: 10.1186/1743-7075-10-59

                Received: 14 April 2013

                Accepted: 24 September 2013

                Published: 2 October 2013



                Lower serum total (TC), high-density lipoprotein (HDL-C) and low-density lipoprotein cholesterols (LDL-C) have been linked to an increased risk of cancer in various sites, but its underlying mechanism remains unclear. In an attempt to clarify the association between cholesterol levels and oxidative DNA damage, we investigated the relationship between serum cholesterol and urinary 8-hydroxydeoxyguanosine levels in a Japanese working population.


                The study subjects were 294 men and 209 women aged 21-66 years in two Japanese municipal offices. Urinary 8-hydroxydeoxyguanosine (8-OHdG) was measured using an automated high-pressure liquid chromatography. Linear regression analysis was used to examine the associations of urinary 8-OHdG with TC, HDL-C and LDL-C levels with adjustment for sex, age, smoking and body mass index. Subgroup analyses were conducted by smoking status in men and age in women. Analysis of covariance was employed to estimate adjusted means of urinary 8-OHdG across TC category.


                After multivariate adjustment, urinary 8-OHdG levels were inversely associated with serum TC levels (β = −0.0015, p < 0.05) and LDL-C levels (β = −0.0012, p = 0.07). The inverse association with TC was apparent among smoking men (β = −0.0017, p < 0.05) and among women aged less than 48 years (β = −0.0040, p < 0.01). 8-OHdG decreased as TC increased (up to 219 mg/dL); subjects with TC levels of <160 mg/dL had a 17.4% higher adjusted mean of 8-OHdG than did those with TC levels of 200–219 mg/dL.


                Results suggest that circulating low TC levels are associated with higher oxidative DNA damage.


                Oxidative stress 8-hydroxydeoxyguanosine (8-OHdG) Epidemiologic studies Cross-sectional studies High-density lipoprotein (HDL-C) Low-density lipoprotein (LDL-C) Total cholesterol





                The high performance liquid chromatography


                Body mass index


                Total cholesterol


                Low-density lipoprotein cholesterol


                High-density lipoprotein cholesterol.


                Lower circulating total (TC) [13], high-density lipoprotein (HDL-C) [4] and low-density lipoprotein cholesterols (LDL-C) [5] have been shown to be associated with an increase risk of total cancer, as well as cancer of the lung, prostate, stomach or colon [6, 7]. Although these observed associations have been ascribed to the presence of preclinical cancer that decreases cholesterol levels [8, 9], the association remained significant in several studies even after excluding cancer incidence that occurred during early period of follow up [2, 6]. Thus, controversy continues whether low cholesterol increases cancer risk.

                A clue to this question may be obtained from biomarker study linking low cholesterol to carcinogenesis in a healthy population. Oxidative DNA stress is thought to play a major role in carcinogenesis [10]. 8-hydroxydeoxyguanosine (8-OHdG) is a reliable marker of oxidative DNA damage and its concentrations in urine have been shown to predict cancer risk [11]. To our knowledge, only two studies examined the association between urinary 8-OHdG and serum cholesterol and their results are conflicting. Sakano et.al. reported a positive association between LDL-C and urinary 8-OHdG and no association between TC and 8-OHdG [12]. In contrast, Miyamaoto et al. found no apparent association between TC/HDL-C and urinary 8-OHdG [13]. These results, however, may be limited due to the use of ELISA method in measuring 8-OHdG, which is less accurate than the high performance liquid chromatography (HPLC) method [14].

                We hypothesized that oxidative DNA damage would be increased in persons with low TC/HDL-C/LDL-C levels. Here, we examined the association between these lipids and urinary 8-OHdG levels measured by using HPLC in an apparently healthy working population.


                Study subjects

                Figure 1 shows flowchart of study protocol. In July and November, 2006, a health survey was conducted among municipal employees of two offices in northeastern Kyushu, Japan, as described elsewhere [15]. Full-time employees were invited to participate in the survey (n = 601) and 547 responded (age range, 21-67 years; response rate, 91.0%). Study participants were asked to fill out the survey questionnaire beforehand, which were checked by research staff for completeness. Also obtained were data that were routinely collected in the health examination, including job title, anthropometric measurements, biochemical data, and information about medical history, smoking, physical activity and alcohol drinking.
                Figure 1

                Flowchart of study protocol.

                We excluded subjects with a history of cancer (n = 8), cardiovascular disease (n = 4), cerebrovascular diseases (n = 6) or diabetes (n = 12), subjects who were currently under the care of physician due to chronic liver disease (n = 2) or nephritis (n = 1), subjects who were receiving medication for hyperlipidemia (n = 3) and pregnant women (n = 2). We further excluded subjects who had missing information on any of the variables used in the present analysis. Some participants had two or more conditions for exclusion. After exclusion, 503 (294 Japanese men and 209 women) were eligible for analysis. The protocol of the health study was approved by the ethics committee of the National Center for Global Health and Medicine, and the written informed consent was obtained from each subjects.

                Measurement of serum cholesterol levels and urinary 8-OHdG

                During the health checkup, blood and urine samples were obtained. Serum TC, HDL-C and triglycerides were measured by using Quick auto neo T-Cho (Shino-Test Co., Tokyo), Cholestest N HDL (Daiichi Kagaku-Co., Tokyo), Wako L-Type (Wako Co. Tokyo), respectively. Among participants with fasting blood samples (n = 481), LDL-C was estimated according to the Friedewald formula: [LDL-C = TC-HDL-C-triglycerides/5]. Urinary 8-OHdG and creatinine were determined by HPLC method [14]. The accuracy of the measurement, estimated from the recovery of an added 8-OHdG standard, was 90-98%. When the same urine sample was analyzed three times, the variation of the data was within 7%.

                Data analysis

                For continuous variables, normality was checked before statistical analysis. 8-OHdG levels were adjusted for urinary creatinine levels and log-transformed for association analyses. Multiple linear regression analyses were used to examine the associations of urinary 8-OHdG with TC, HDL-C and LDL-C levels while adjusting for sex, age (continuous), smoking (smoker or nonsmoker including past smoker) and body mass index (BMI) (kg/m2, continuous). To test the interaction, we added an interaction term of sex and each TC, HDL-C, LDL-C levels to the model. Subgroup analyses were conducted by smoking status in men (smoker and nonsmoker) and age group in women (<48 and ≥48 years, the median age of menopause in Japanese women [16]). Due to few female smokers (n = 4), subgroup analysis by smoking status was not performed in women.

                After subjects were divided into seven groups according to TC concentrations (<160, 160-179, 180-199, 200-219, 220-239, 240-259 or ≥260 mg/dL), analysis of covariance was employed to estimate the means of log-transformed 8-OHdG and their standard errors. The means and their 95% confidence limits in log-scale were then back-transformed. A trend test was performed by treating TC as a continuous variable in a multivariable regression analysis. We repeated the above analyses by adding other covariates, including physical activity, alcohol consumption, hypertension status and job-title. All statistical tests were two-tailed and considered to be statistically significant at the 0.05 level. All analyses were done with Stata, version 9.1.


                The 294 subjects were men (58.4%), the mean age was 42.4 years old (range 21-66), and mean (±SD) BMI was 22.5 ± 3.5 kg/m2. As shown in Table 1, age and BMI were positively correlated with TC levels. Mean (SD) TC was 206 ± 33 mg/dL (men: 209 ± 33 mg/dL; women: 201 ± 34 mg/dL), HDL-C was 61.5 ± 16 mg/dL (men: 55.7 ± 14 mg/dL; women: 69.8 ± 15 mg/dL) and LDL-C was 122 ± 30 mg/dL (men: 125 ± 30 mg/dL; women: 117 ± 30 mg/dL). Median (interquartile range) 8-OHdG concentration was 3.01 (2.37, 4.03) μg/g creatinine (men: 3.09 [2.43, 3.97]; women; 2.99 [2.24, 4.21]), ranging from 0.8 to 10.0 μg/g creatinine.
                Table 1

                Characteristics of study subjects by serum total cholesterol concentrations


                Serum total cholesterol concentrations (mg/dL)



















                Men subjects,%









                Age (S.D.), y

                36 (10)

                37 (9)

                41 (12)

                43 (9)

                46 (10)

                48 (9)

                49 (9)

                42 (11)

                BMI (S.D.), kg/m2

                21.5 (3.3)

                21.1 (2.6)

                21.8 (3.3)

                22.6 (3.7)

                23.4 (3.5)

                24.1 (3.5)

                24.1 (3.5)

                22.5 (3.5)

                Current Smoker,%









                BMI Body mass index.

                Table 2 shows the results of multiple linear regression analysis. For overall subjects, urinary 8-OHdG levels were significantly, inversely associated with serum TC levels (β = −0.0015, p < 0.01) and marginally, inversely associated with LDL-C levels (β = −0.0012, p = 0.07) with adjustment for age, sex, smoking status and body mass index. Urinary 8-OHdG levels were not associated with HDL-C levels (β = −0.0010, p = 0.46). There was no significant interaction of sex on the association between urinary 8-OHdG and cholesterols.
                Table 2

                Regression coefficients in multiple linear regression analyses between serum cholesterols and urinary 8-OHdG



                Total cholesterol













                Total subjects























































                 Age < 48











                 Age ≥ 48











                8-OHdG 8-hydroxydeoxyguanosine, S.E standard error, HDL high-density lipoprotein, LDL low-density lipoprotein.

                All analyses were adjusted for sex, age, body mass index and smoking status.

                LDL-cholesterol was estimated by applying the Friedewald’s formula (LDL cholesterol = total cholesterol - HDL cholesterol - trigriceride/5) only among subjects with fasting blood samples (n = 481).

                Subgroup analysis showed that the inverse association with TC was statistically significant among smoking men (β = −0.0017, p < 0.05) and among women aged less than 48 years (β = −0.0040, p < 0.01), but not among non-smoking men (β = −0.0015, p = 0.15) and among women aged 48 years or older (β = −0.0014, p = 0.47). In women, urinary 8-OHdG levels were significantly, inversely associated with LDL-C (β = −0.0030, p < 0.05). Moreover, a marginally significantly, inversely association between with HDL-C and urinary 8-OHdG levels was observed among women aged less than 48 years (β = −0.0052, p = 0.08).

                Figure 2 shows mean urinary 8-OHdG by TC levels with adjustment for age, sex, BMI and smoking status. There was a decreasing trend of 8-OHdG with increasing TC (up to 219 mg/dL). The multivariate adjusted means (standard errors) of urinary 8-OHdG levels from the lowest to the highest group of serum TC levels were 3.36 (0.50), 3.19 (0.34), 3.08 (0.26), 2.86 (0.22), 3.02 (0.29), 2.82 (0.37), 2.94 (0.46) (p for trend < 0.05). Subjects with TC levels of <160 mg/dL had a 17.4% higher adjusted mean of 8-OHdG than did those with TC levels of 200-219 mg/dL. Results were virtually unchanged after adding other covariates, including alcohol drinking, physical activity, job-title and hypertension status.
                Figure 2

                Mean urinary 8-hydroxydeoxyguanosine (8-OHdG) levels by serum total cholesterol concentrations. Bar indicates geometric means levels. Error bar indicates upper limit of 95% confidence interval. *Adjusted for age, sex, body mass index and smoking status.


                We hypothesized that oxidative DNA damage is increased in persons with low cholesterol levels. In the present study of a healthy working population, we found a statistically significant inverse association between serum TC and urinary 8-OHdG concentrations even after adjustment of confounding factors. Subgroup analysis showed that the inverse association was more pronounced in smoking men and younger women. This is one of few epidemiological studies which examined the association between TC levels and oxidative DNA damage [12, 13].

                Available data on associations between circulating cholesterol levels and markers of oxidative DNA damage are limited and conflicting. In a study of 677 middle-aged city officers, urinary 8-OHdG concentrations were statistically, positively associated with LDL-C, but not with TC [12]. In another study among 90 non-smokers who participated in a health program, a weak non-significant inverse association was observed between TC and urinary 8-OHdG levels (r = −0.155) [13]. In measuring urinary 8-OHdG, these studies used ELISA method, which is less accurate than HPLC method [17].

                In the present study, a significant inverse association between TC and urinary 8-OHdG levels was found among smokers (β = −0.0017, p < 0.01) but not among non-smokers (β = −0.0015, p = 0.15) in men. However, the estimated slope (β) of smokers was similar to that of nonsmokers. In women, the association was more apparent among women aged less than 48 years (β = −0.0040, p < 0.01) than those aged 48 years or older (β = −0.0014, p = 0.47). This result may suggest that menopausal status may modify the association between circulating TC and oxidative stress. Such differential association has also been observed in epidemiological studies on cancer. For instance, low serum TC was associated with an increased risk of breast cancer among pre-menopausal women, but not among post-menopausal women [18].

                Biological mechanism underlying the association between lower serum TC and higher oxidative DNA damage remains unclear. Cholesterol is an important structural lipid for maintaining cell functions. In addition, cholesterol plays an important role in the absorption of lipid-soluble vitamins including vitamin E, the major membrane-bound antioxidant, and controls the flow of these vitamins in and out of cell membranes [19, 20]. Persons with low cholesterol levels may thus have a decreased antioxidant capacity, leading to increased oxidative DNA damage.

                In women aged less than 48 years, urinary 8-OHdG levels were significantly, inversely associated with LDL-C (β = −0.0041, p < 0.05), and marginally significantly associated with HDL-C levels (β = −0.0052, p = 0.08). Plausible mechanisms underlying these associations are unclear, but the following has been suggested. HDL-C can prevent oxidation of LDL-C [21]. Thus, LDL-C derived oxidized stress might be increased among subjects with lower levels of HDL-C. Meanwhile, LDL-C level itself is not associated with oxidized LDL-C level [22]. Although LDL-C might be partially oxidized, most of the remaining unoxidized LDL-C might play a protective role against oxidative stress.

                Major strengths of the present study include high response rate (91%), control of known background and lifestyle factors associated with oxidative DNA damage, and use of reliable technique (HPLC) in measuring biomarker of oxidative DNA damage [17]. Limitations of the study also warrant mention. The cross-sectional design of this study does not allow us to infer causality. Because study participants were employees of municipal offices in Japan, the present findings may not be applicable to populations with different background. Finally, the sample size of this study may not be sufficient to detect a modest association.

                In conclusion, serum TC levels were inversely associated with urinary 8-OHdG concentrations in a healthy working population. This finding suggests that oxidative DNA damage is increased in persons with low cholesterol levels, and thus may support a link of low TC to carcinogenesis.



                This work was supported by a Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan; and Grant-in-Aids for Scientific Research (C) (no. 18590601) and (B) (no. 21390213) from the Japan Society for the Promotion of Science (To Dr Mizoue). We thank Tamani Hatano, Yasumi Kimura, Akihiro Tanaka and Yuko Ejima (Kyushu University) Mio Ozawa (Fukuoka Women’s University): and Akiko Hayashi and Kie Nagao (International Medical Center of Japan) for their help in data collection.

                Authors’ Affiliations

                Department of Epidemiology and Prevention, Clinical Research Center, National Center for Global Health and Medicine
                Department of Safety and Health, Tokyo Gas Co., Ltd.
                Laboratory of Nutrition Chemistry, Faculty of Agriculture, Kyushu University
                Institute of Industrial Ecological Sciences, Department of Environmental Oncology, University of Occupational and Environmental Health


                1. Hiatt RA, Fireman BH: Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis. 1986, 39: 861-870. 10.1016/0021-9681(86)90034-2.View Article
                2. Schuit AJ, Van Dijk CE, Dekker JM, Schouten EG, Kok FJ: Inverse association between serum total cholesterol and cancer mortality in Dutch civil servants. Am J Epidemiol. 1993, 137: 966-976.
                3. Knekt P, Reunanen A, Aromaa A, Heliovaara M, Hakulinen T, Hakama M: Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol. 1988, 41: 519-530. 10.1016/0895-4356(88)90056-X.View Article
                4. Jafri H, Alsheikh-Ali AA, Karas RH: Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol. 2010, 55: 2846-2854. 10.1016/j.jacc.2009.12.069.View Article
                5. Alsheikh-Ali AA, Trikalinos TA, Kent DM, Karas RH: Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol. 2008, 52: 1141-1147. 10.1016/j.jacc.2008.06.037.View Article
                6. Eichholzer M, Stahelin HB, Gutzwiller F, Ludin E, Bernasconi F: Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study. Am J Clin Nutr. 2000, 71: 569-574.
                7. Rose G, Blackburn H, Keys A, Taylor HL, Kannel WB, Paul O, Reid DD, Stamler J: Colon cancer and blood-cholesterol. Lancet. 1974, 1: 181-183.View Article
                8. Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, Ueshima U: The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis. 2007, 190: 216-223. 10.1016/j.atherosclerosis.2006.01.024.View Article
                9. Wannamethee G, Shaper AG, Whincup PH, Walker M: Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ. 1995, 311: 409-413. 10.1136/bmj.311.7002.409.View Article
                10. Ames BN: Endogenous DNA damage as related to cancer and aging. Mutat Res. 1989, 214: 41-46. 10.1016/0027-5107(89)90196-6.View Article
                11. Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen HE: Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 1992, 13: 2241-2247. 10.1093/carcin/13.12.2241.View Article
                12. Sakano N, Wang DH, Takahashi N, Wang B, Sauriasari R, Kanbara S, Sato Y, Takigawa T, Takaki J, Ogino K: Oxidative stress biomarkers and lifestyles in Japanese healthy people. J Clin Biochem Nutr. 2009, 44: 185-195. 10.3164/jcbn.08-252.View Article
                13. Miyamoto M, Kotani K, Ishibashi S, Taniguchi N: The relationship between urinary 8-hydroxydeoxyguanosine and metabolic risk factors in asymptomatic subjects. Med Princ Pract. 2011, 20: 187-190. 10.1159/000319774.View Article
                14. Kasai H, Svoboda P, Yamasaki S, Kawai K: Simultaneous determination of 8-hydroxydeoyguanosine, a marker of oxidative stress, and creatinine, a standardization compound, in urine. Ind Health. 2005, 43: 333-336. 10.2486/indhealth.43.333.View Article
                15. Hori A, Mizoue T, Kasai H, Kawai K, Matsushita Y, Nanri A, Sato M, Ohta M: Body iron store as a predictor of oxidative DNA damage in healthy men and women. Cancer Sci. 2010, 101: 517-522. 10.1111/j.1349-7006.2009.01394.x.View Article
                16. Kono S, Sunagawa Y, Higa H, Sunagawa H: Age of menopause in Japanese women: trends and recent changes. Maturitas. 1990, 12: 43-49. 10.1016/0378-5122(90)90059-F.View Article
                17. Division of Health Promotion and Nutrition: Annual report of the national nutrition survey in 2004. 2006, Tokyo, Japan: Tokyo Daiichi Publishing Co
                18. Kelsey JL, Berkowitz GS: Breast cancer epidemiology. Cancer Res. 1988, 48: 5615-5623.
                19. Burton GW, Ingold KU: Vitamin E as an in vitro and in vivo antioxidant. Ann N Y Acad Sci. 1989, 570: 7-22. 10.1111/j.1749-6632.1989.tb14904.x.View Article
                20. Stahl W, van der Berg H, Arthur J, Bast A, Dainty J, Faulks RM, Gatner C, Haenen G, Hollman P, Holst B, Kelly FJ, Polidori MC: Bioavairability and metabolism. Mol Aspects Med. 2002, 23: 39-100. 10.1016/S0098-2997(02)00016-X.View Article
                21. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM: HDL as a biomarker, potential therapeutic target, and therapy. Diabetes. 2009, 58: 2711-2717. 10.2337/db09-0538.View Article
                22. Inoue T, Inoue K, Maeda H, Takayanagi K, Morooka S: Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. Clin Chim Acta. 2001, 305: 115-121. 10.1016/S0009-8981(00)00426-5.View Article

                This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.